Radiation Oncology

Why PGY Zero Matters More in Radiation Oncology

Radiation oncology runs one of the smallest matches in American medicine. The total number of positions available each cycle is measured in the low hundreds—a figure an order of magnitude smaller than internal medicine or emergency medicine. That arithmetic has a direct consequence: the margin between a competitive and a non-competitive application is narrow, and the window to build that margin is almost entirely in the pre-clinical and early clinical years.

Programs in this field are evaluating a short list of proxies for future academic productivity and clinical judgment: research output, mentor relationships, rotation performance, and the coherence of an intellectual narrative. None of those proxies are built in the four months before ERAS opens. The applicants who match at programs aligned with their interests typically began positioning twelve to twenty-four months before submission. The applicants who scramble or go unmatched are often not weaker physicians—they are physicians who discovered the timeline late.

This page is organized around the things you can control, in the order you need to control them. If you are reading this in MS1 or early MS2, you have a full runway. If you are reading this later, the calendar section will show you where to compress without cutting what actually matters.

The Radiation Oncology Match Landscape

Radiation oncology participates in the NRMP Main Residency Match. The specialty consistently offers among the fewest positions of any advanced specialty. For current position counts, fill rates, and unfilled program data, consult the NRMP's annual Results and Data publication for the most recent match cycle—figures shift year to year and the ones worth citing are the ones from the cycle you are actually entering. See the PGY Zero data pages for a summary cross-referenced to the current season.

Several structural features of this match are stable enough to describe:

• IMG competitiveness is real but conditional. International medical graduates do match into radiation oncology, including at research-intensive programs. The condition is a research portfolio and mentor network that is demonstrably equivalent to the strongest US MD applicants. An IMG without meaningful radiation oncology research and at least one strong US-based letter from a radiation oncologist faces a substantially narrower set of realistic programs. This is a calibration fact, not a ceiling.
• The unfilled rate fluctuates. Unlike some specialties with chronic unfilled seats, radiation oncology has historically run close to fully filled, though individual program-level vacancies do appear in the SOAP. Do not count on SOAP as a strategy; treat it as an insurance policy with uncertain actuarial value in this specialty.
• Couples matching introduces complexity. With a small position pool, couples matching constrains geography in ways that are more consequential here than in larger specialties. If you are couples matching, begin geographic planning earlier than the standard advice suggests.
• Program director surveys consistently cite research productivity and specialty-specific letters as top selection criteria. The AAMC and ASTRO have both published selection factor data; the PGY Zero data pages link to the most current versions. Research and letters are not soft considerations—they are the primary differentiators at the score threshold most competitive applicants share.

Core Academic Metrics That Move the Needle

Radiation oncology programs use USMLE scores as a screen before holistic review begins. The practical implication: a Step 1 or Step 2 CK score below the competitive range for this specialty may prevent an application from being read in full, regardless of research or letters. For current competitive score ranges, see the PGY Zero specialty data page, which aggregates NRMP match data and program director survey results by application year.

Several points about interpreting your own transcript:

• Step 1 pass/fail and Step 2 CK. With Step 1 now pass/fail for most applicants, Step 2 CK carries more screening weight than it did in prior cycles. A strong Step 2 CK score can partially offset a mediocre Step 1 numeric score for those who have one. A Step 2 CK score in the bottom quartile of what programs typically see is harder to contextualize. Take it seriously and take it early enough to retake if needed.
• Clerkship grades. Honors in the radiation oncology rotation itself is expected. Honors or high pass in core clerkships—internal medicine, surgery, pediatrics—signals the broad clinical foundation programs want to see. A single pass grade in a core clerkship is noticed; multiple pass grades require explanation.
• AOA and Gold Humanism Honor Society. These are positive signals where available, but their absence is not disqualifying. Programs that see a robust research portfolio and strong specialty letters do not make AOA a prerequisite.
• Grade trends matter. An upward trajectory from pre-clinical to clinical years is read as signal. A flat or declining trajectory raises questions that your personal statement and letters will need to address directly, not indirectly.

Honest calibration: if your Step 2 CK score and clerkship grades put you in the lower half of the competitive distribution for radiation oncology, that does not eliminate the path—but it shifts the emphasis onto research productivity and mentor advocacy more heavily than for an applicant with top scores. Both levers need to be working simultaneously, not sequentially.

Your First Radiation Oncology Rotation: How to Find It and Crush It

Most medical schools offer one or zero required radiation oncology exposures. That means most applicants need to arrange a rotation themselves, and they need to do it before their MS3 clinical year is over—ideally during MS3 if the schedule allows, to leave MS4 for strategically chosen away rotations.

Finding the Rotation

Start with your own institution. If your school has a radiation oncology department, contact the program coordinator directly and ask whether medical student observerships or sub-internship rotations are available. Frame the request concisely: your year of training, your interest in the specialty, and the dates you are available. Program coordinators handle volume; a clear, brief email gets a response faster than a long one.

If your institution does not have a radiation oncology program—common at community-based medical schools—identify the nearest academic medical center with an accredited residency and make the same request. This is a cold contact, and the response rate is real but not guaranteed. Send to three to five programs simultaneously rather than waiting on one response before sending the next.

Your email should include: your school and year, a one-sentence statement of your interest in the specialty, your available dates, and a brief note about any research interest. Attach a current CV. Do not attach a personal statement at this stage.

What to Do During the Rotation

A radiation oncology rotation exposes you to treatment planning, simulation, weekly on-treatment visits, multidisciplinary tumor boards, and consultation. Each of those environments is both a learning opportunity and an evaluation context. Specific behaviors that function as evaluation signals:

• Prepare briefly for tumor board cases the night before—know the staging, the standard treatment options, the relevant trial that informed the recommendation. Attendings notice who has read.
• Ask questions that demonstrate you have thought about the physics and the biology, not just the clinical algorithm. Radiation oncology is intellectually distinctive precisely because it sits at the intersection of oncology, physics, and imaging. Questions that reflect that intersection signal genuine fit.
• Identify one faculty member whose research interests overlap with yours and ask for thirty minutes to discuss their work. Not to ask for a project—to understand the work. Projects come from demonstrated curiosity, not from requests.
• Write a brief summary of something you observed or learned and send it to the faculty member you connected with most closely. This is not flattery; it is a record that you engaged intellectually and can synthesize.

Converting the Rotation Into a Letter

A strong letter from a radiation oncologist who observed you directly is categorically more valuable than a strong letter from any other specialty. To earn that letter, the faculty member needs specific material to write from. Give them two things at the time you ask: a bullet-point summary of what you did during the rotation (cases you worked up, presentations you gave, anything that stood out), and a copy of your current personal statement draft. Ask whether they are willing to write a letter that speaks to your clinical and intellectual fit for the specialty—not just a letter confirming you rotated there. The difference between those two asks is large.

Building a Research Portfolio Before MS3

Radiation oncology residency programs evaluate research output more heavily than nearly any other specialty of comparable size. This is in part because the specialty has a strong academic identity, and in part because the small number of positions means programs can afford to be selective on research criteria. An application with no research is an application without a primary differentiator in the pool that matters.

What Counts and What Counts More

Research valued in radiation oncology spans several categories:

• Translational and laboratory research. Basic science with direct application to radiation biology—DNA damage and repair, tumor microenvironment, fractionation effects—carries strong signal, particularly at research-intensive programs. This type of work typically requires a dedicated year (often structured as a research year or dual-degree work) to produce first-author output.
• Clinical outcomes and retrospective series. Accessible without a research year if you identify a mentor with data and a question. A well-executed retrospective outcomes analysis submitted to a specialty journal is legitimate research. Many matched applicants have a first-author outcomes paper as their anchor publication.
• Dosimetry and treatment planning studies. Less common as medical student work, but valued by programs with strong physics faculty. If you have a physics background or a genuine interest in planning, this is an underused entry point.
• Systematic reviews and meta-analyses. Publishable, but carry less weight than original data work. Useful as a supplementary publication, not as a primary research identity.

Finding a Mentor

ASTRO (American Society for Radiation Oncology) is the professional home of this specialty. The ASTRO website lists member institutions and faculty profiles. Use it as a directory to identify faculty at programs where you might rotate or apply, and to understand what research questions are active in the field. The ASTRO annual meeting, held each fall, has a medical student program that functions as an introduction to the specialty's research community.

When cold-contacting potential research mentors, be specific about what you have read and what question interests you. A message that says "I am interested in radiation oncology and would like to work in your lab" will not produce a mentorship. A message that says "I read your 2023 paper on adaptive re-planning for rectal cancer and I am curious whether the dosimetric endpoints you used are being prospectively validated" will sometimes produce a conversation. Conversations produce projects.

Realistic Publication Timeline

A student who begins a research relationship in MS1 or early MS2 has realistic potential for one first-author peer-reviewed publication and one or two co-authored publications by the time ERAS opens in MS4. A student who begins in MS3 has realistic potential for one submitted or in-revision paper and possibly one published. Either is a functional portfolio. A student who begins research in MS4 faces a structural problem that effort alone cannot fully solve—submitted but not yet accepted work is visible in ERAS, but programs weight publications that exist.

Abstracts and presentations at regional or national meetings (including ASTRO) are supplementary signals, not substitutes for publications. List them accurately. Do not inflate their weight in your own self-assessment.

Choosing Away Rotations Strategically

Away rotations in radiation oncology function as extended auditions. This is widely understood in the field and it is not cynical—programs have a small cohort each year and they are selecting people they will work with closely for four to five years. Demonstrating clinical and interpersonal fit in person carries genuine weight.

How Many to Do

Most competitive applicants do two to three away rotations. One is the minimum for an applicant who does not have a strong home program. More than three begins to carry scheduling costs and financial costs that usually do not translate into proportional benefit. Allocate your away rotation budget toward programs where you have a realistic chance of ranking highly and where you would genuinely go.

How to Choose Programs

Sort programs along two axes before selecting: research intensity and clinical philosophy. Research-intensive programs at major academic centers are looking for applicants who can immediately contribute to ongoing work—your portfolio, your mentor connections, and your ability to discuss current research questions in the specialty are evaluated directly. Programs with a stronger clinical training emphasis may weight rotation performance and interpersonal fit more heavily relative to publication count.

Neither axis is superior. The question is fit. An applicant with two first-author publications and a strong translational mentor is a strong candidate at a research-intensive program. The same applicant with weak interpersonal self-awareness may not match there. An applicant with one co-authored paper and outstanding clinical evaluations may match well at a program that trains excellent clinical radiation oncologists. Know what you are and apply where that is valued.

What Programs Are Evaluating During Away Rotations

• Clinical preparation and work ethic (the basics, but they still matter)
• Intellectual engagement with physics and biology, not just clinical algorithms
• Ability to function in a small, close team—radiation oncology departments are small by nature
• Whether you ask the questions a future resident would ask, not the questions a visiting student performs
• How you handle not knowing something—intellectual honesty is read as a training signal

After the rotation ends, a brief, specific thank-you to the faculty you worked most closely with is appropriate. It is not a strategy; it is professional conduct. If a letter was implicit or discussed, follow up with the materials described in the letters section below.

Mentorship and Networking Inside ASTRO

ASTRO offers medical student membership at a reduced rate. Membership gives you access to the annual meeting abstract and program, the journal International Journal of Radiation Oncology Biology Physics (the primary specialty journal), and access to career development resources including the Residents/Fellows in Radiation Oncology section (RFO), which has programming specifically for students considering the specialty.

The ASTRO annual meeting is the single highest-leverage networking event available to a radiation oncology applicant before interview season. Faculty from programs across the country attend. Students who present an abstract—even a poster—have a natural entry point into conversations that would otherwise require a cold email. If you have any research in progress, prioritize submitting an abstract to the annual meeting in the cycle before your application year. The abstract deadline typically falls in late spring; see the current season timeline for the specific date.

Building a Mentor Structure That Works

One primary mentor is not enough for a competitive radiation oncology application. The structure that works:

• Primary mentor: A radiation oncologist, ideally at your home institution or a program where you have rotated, who knows your work, your trajectory, and can write your strongest letter. This person should be able to speak to your research, your clinical performance, and your fit for the specialty with specific evidence.
• Geographic backup mentors: Two radiation oncologists at programs outside your home region who have interacted with you substantively—at a meeting, during an away rotation, through a research collaboration. Their value is contextual: they can speak to your file informally if asked by colleagues at programs you apply to, and they can provide letters if your primary mentor relationship is insufficient for some reason.

Mentor relationships are built through demonstrated engagement over time, not through single interactions. The sequence is: rotation or research contact → follow-up intellectual engagement → request for mentorship framed around specific goals → reciprocal investment. A mentor who is asked to write a letter after one email exchange cannot write a strong letter regardless of their intention.

Letters of Recommendation: Timing and Targeting

Radiation oncology programs expect three to four letters of recommendation. The strong expectation—reinforced by program director survey data—is that the majority of letters come from radiation oncologists who have directly observed the applicant clinically or in research. A letter from a non-radiation oncologist, even a prominent one, carries weight primarily as a supplementary signal. It does not substitute for a radiation oncology letter.

Composition of a Strong Letter Set

• Two to three letters from radiation oncologists who have observed you in clinical or research settings
• One letter from a non-radiation oncologist—a research mentor from another specialty, a core clerkship director, or a respected faculty member who can speak to qualities not captured by specialty-specific letters

Programs are aware that students from schools without home radiation oncology programs cannot always produce three specialty letters. If that is your situation, two radiation oncology letters—one from a home or early rotation contact, one from an away rotation—plus one strong research mentor letter is a viable set. Be transparent in your application about where your training has taken place.

When and How to Ask

Ask at the end of a rotation, in person if possible, after you have had a conversation with the faculty member that made your interest and your fit visible. Asking by email two weeks after a rotation ends is less effective than asking in the last few days when the interaction is current. Give writers a deadline that is two to three weeks before the actual ERAS deadline, and provide them:

• A bullet-point summary of what you did during the rotation and what stood out
• Your current CV
• A draft of your personal statement
• A brief note on what you hope they might be able to address—research engagement, clinical aptitude, interpersonal fit, intellectual curiosity. Be explicit. Writers who know what selectors are looking for write more targeted letters.

Follow up once, gently, two weeks before your deadline if you have not received a confirmation that the letter is in progress.

Crafting a Personal Statement That Signals Commitment

The radiation oncology personal statement has one primary function: to make a convincing, evidence-based case that you chose this specialty through intellectual engagement with its specific content—not through specialty tourism or process of elimination. Programs read enough statements to recognize the difference immediately. The statements that work are the ones where the commitment is demonstrated through specificity, not asserted through enthusiasm.

Structural Framework

• Opening (one to two paragraphs): A specific moment or encounter that introduced you to a concept, a patient, or a problem that only radiation oncology addresses. Not an oncology story. Not a cancer story. A radiation oncology story—something that required you to engage with the intersection of physics, biology, and oncology that defines this field.
• Intellectual arc (one to two paragraphs): How your research and clinical exposure developed that initial encounter into a genuine understanding of what the specialty involves and what its open questions are. This is where your research appears—not as a list, but as an intellectual trajectory.
• Training goals (one paragraph): What you want to learn to do, and why that requires a residency program with the characteristics you are applying to. Specific enough to be credible; not so specific that it reads as flattery.
• Close (one paragraph): Brief, direct, forward-looking. Not a summary. Not a motivational declaration.

Annotated Example: Opening Paragraph

Weak opening: "Since a young age, I have been fascinated by the intersection of technology and medicine. When I first shadowed in a radiation oncology clinic during my second year of medical school, I knew I had found my specialty."

Why this fails: The statement is asserted, not demonstrated. "Fascination" and "knew I had found my specialty" are conclusions without evidence. The reader learns nothing about the applicant's intellectual engagement. Any applicant could have written this sentence. Program directors see variants of it hundreds of times per cycle.

Stronger opening: "During a third-year radiation oncology rotation, I watched a dosimetrist rebuild a treatment plan in real time after a patient's anatomy changed midway through a head and neck course. The question that stayed with me—whether we could predict which patients would require adaptive replanning before toxicity accumulated—led me to a retrospective analysis of forty-three cases with Dr. [X], which became the first study I understood from hypothesis to submission."

Why this works: It locates a specific intellectual problem. It shows a causal chain: observation → question → action → outcome. The research appears as a consequence of curiosity, not as a credential being displayed. The reader learns something about how this applicant thinks. The opening is differentiable—another applicant cannot honestly copy it because it is specific to an experience.

The personal statement is not the place to address liabilities. Scores, gaps, and retakes are addressed in the relevant ERAS fields or in a separate optional statement if the application provides one. A personal statement that spends a paragraph explaining a Step 1 retake has wasted a paragraph that could have demonstrated intellectual fit.

Sub-Specialty Tracks: Which Niche to Signal Early

Radiation oncology is organized by disease site in practice and increasingly in training. The major clinical tracks include gastrointestinal (GI), genitourinary (GU), breast, central nervous system (CNS), head and neck, thoracic, gynecologic, pediatric, and particle therapy (primarily proton therapy). Each has a distinct research literature, a distinct set of active clinical trials, and a distinct fellowship pathway for those who pursue subspecialization after residency.

Whether to Signal a Focus at the Application Stage

This is a genuine strategic question, and the answer depends on your specific situation:

• Signal a focus if: You have published research in a specific disease site, your primary mentor is a disease-site specialist, and your intellectual narrative coherently builds toward a subspecialty question. Consistency across research, mentorship, and stated interest is readable as genuine and differentiating.
• Stay broad if: Your research crosses disease sites, your mentor is a generalist or a methodologist, and your stated interest in a specific site would require you to misrepresent the actual arc of your training. Breadth is not a weakness in radiation oncology—many programs train general radiation oncologists and expect MS4 applicants to still be forming their subspecialty interests.
• Particle therapy: Signaling interest in proton or heavy ion therapy is appropriate if you have had exposure to a proton center and have engaged with the clinical evidence debates in that space. Signaling particle therapy interest without substantive engagement reads as aspirational rather than informed.
• Pediatric radiation oncology: A genuine subspecialty with a small number of training positions. If this is a serious interest, it should appear in your research and your rotations—not only in your personal statement.

Whatever you signal, be prepared to defend it in an interview with specific knowledge of the current evidence base, active controversies, and open questions in that disease site. Interest without knowledge does not survive the interview context.

Contextualizing Application Liabilities Before ERAS Opens

This section addresses the parts of your application that require proactive work before submission. The framing throughout: every liability has a context, and the context needs to be provided by you, not inferred by a program director reading between lines.

USMLE Retakes

A retake is visible in ERAS. Programs will see the score history. The relevant question for a program director is not "did this applicant retake"—it is "what does the trajectory tell me." A retake followed by a substantially improved score, combined with a strong Step 2 CK, is a net neutral to mild positive for many programs. A retake with minimal score improvement leaves the original question unanswered. If you have a retake in your history, address it directly in the additional comments field if the application provides one. State what changed in your preparation and what the outcome was. Do not volunteer it in the personal statement and do not hide from it in interviews.

Leave of Absence or Gap Year

A leave of absence or gap year that was used productively—research, clinical exposure, a personal circumstance that was resolved—requires a clear, brief explanation. "I took a gap year to complete a research project, which resulted in a first-author submission currently under review" is a complete explanation. A gap year that is not explained will generate questions in interviews; it is better to answer the question on your terms in the written application than to answer it under interview conditions for the first time.

A Pass Grade in the Radiation Oncology Rotation

This is a meaningful signal to programs, because honors in the rotation is the common expectation for competitive applicants. If you received a pass grade in your home radiation oncology rotation, the most functional response is to perform at a level that earns honors in your away rotations and to obtain letters that specifically address your clinical aptitude. A pass grade from one rotation followed by strong away rotation letters is an addressable situation. Do not try to explain the grade in your personal statement; demonstrate performance through subsequent evaluations.

Low Step 2 CK Score

This is the most structurally difficult liability to address because it enters the screening process before holistic review begins at many programs. If your Step 2 CK score is below the competitive range for this specialty (see current data page), consider retaking it if you have time before the ERAS submission deadline for your cycle. A score improvement is the most direct remedy. If retaking is not feasible, the rest of your application needs to compensate at every other dimension simultaneously—research, letters, and rotation evaluations all need to be in the strongest tier available to you.

A Month-by-Month PGY Zero Action Calendar

This calendar assumes an MS1 or MS2 entry point. If you are entering later in your training, identify your current month and compress the preceding tasks into the time available. The sequence of dependencies matters more than the absolute timing: research precedes publications, relationships precede letters, rotations precede away rotations.

For exact ERAS opening, deadline, rank order list, and match result dates, see the current season timeline on the PGY Zero data pages. Dates change annually and should not be read from static text.

MS1 Year

• Months 1–4: Identify radiation oncology faculty at your institution. Read one recent issue of IJROBP to understand what current research questions look like. Join ASTRO as a medical student member. Begin basic science or outcomes research conversations with one potential mentor—goal is a project with a defined question by the end of this period, not a publication.
• Months 5–8: Begin active research work. Attend one radiation oncology tumor board or clinic if your institution allows student observers at this stage. Establish a CV document and update it as you accumulate any academic activity.
• Months 9–12: Check ASTRO annual meeting abstract deadline (typically spring). If you have preliminary data, consider whether an abstract is submittable. Begin reading the clinical literature in one disease site of particular interest.

MS2 Year

• Months 13–16: Submit ASTRO abstract if data support it. Attend the annual meeting if feasible—student registration is available. Target having a manuscript in draft or in submission by end of MS2.
• Months 17–20: Begin Step 1 preparation in earnest alongside ongoing research. Complete USMLE Step 1. Research activity should continue in parallel—a gap in research during board prep is understandable; a complete stop that is never restarted is not.
• Months 21–24: Arrange your first clinical radiation oncology rotation for early MS3. Contact program coordinators at your home institution first, then external programs. Have your initial letter request conversations identified—you need to know which faculty member you will ask before you arrive at the rotation.

MS3 Year

• Months 25–28: Complete your first radiation oncology rotation. Perform at a level that produces an honors evaluation and a strong letter. Identify away rotation programs—target two to three programs that match your profile and geographic preferences.
• Months 29–32: Complete Step 2 CK. Target a score at or above the competitive range for this specialty before you begin requesting letters in earnest. Submit any pending research manuscripts. Confirm letter writers from your MS3 rotation.
• Months 33–36: Begin away rotation applications. Away rotation scheduling opens at different times for different programs; contact coordinators in this window to understand their process. Drafting of personal statement should begin—not because it will be final, but because early drafts reveal gaps in your narrative that there is still time to address.

MS4 Year: Pre-Submission

• Months 37–40: Complete away rotations. These typically occur in the early MS4 year, before ERAS opens. Request letters from away rotation faculty before you leave the rotation, with the supporting materials described in the letters section. Finalize personal statement draft with specific attention to intellectual arc and program fit language.
• ERAS opens (see current season timeline): Submit a complete application. Incomplete applications—missing transcripts, late letters, unfinished personal statements—create avoidable risk in a specialty where complete applications from competitive candidates are the norm.

MS4 Year: Interview Season Through Match

• Interview season: Radiation oncology interviews are typically held in the fall and early winter. Prepare for interviews using the format below. After each interview, update your rank list notes while the program is current in your memory.
• Rank order list deadline (see current season timeline): Submit your certified rank order list before the deadline. Rank in true preference order—NRMP matching algorithm optimizes for the applicant when lists reflect genuine preference.
• Match week: Know in advance whether you will participate in SOAP if needed, and have your preliminary year position contingency already identified.

Backup Planning Without Burning Bridges

Radiation oncology residency requires a preliminary year—typically one year of internal medicine or surgery—before the advanced four-year radiation oncology training begins. That structure means every radiation oncology applicant is simultaneously applying for both an advanced position (the radiation oncology residency) and a preliminary year position (in medicine or surgery). This is not optional and is not a backup plan; it is a structural feature of the match.

Preliminary Year Selection

Internal medicine preliminary year programs are more numerous than surgery preliminary programs and have historically been more accessible to radiation oncology applicants. Surgery preliminary year positions are available and some radiation oncology programs have a preference for them, but the availability is more limited. When building your application strategy, identify preliminary programs at or near the institutions where you are applying for radiation oncology advanced positions—geographic alignment simplifies logistics and avoids the need to match at a distant preliminary program.

If the Match Does Not Result in a Radiation Oncology Position

An applicant who does not match into radiation oncology in a given cycle has several functional paths:

• SOAP: A small number of radiation oncology positions go unfilled in some cycles. Participating in SOAP requires rapid decision-making and a submitted application already in the system. If SOAP is a realistic possibility you want to keep open, discuss it with your mentor before match week.
• Reapplication: Reapplication to radiation oncology after one cycle is a documented path. The work between application cycles matters: additional research, an additional strong letter, and a clear narrative about what changed since the prior application. Programs do not automatically penalize reapplication; they evaluate what the intervening year produced.
• Preliminary year as a strategic year: Completing a preliminary medicine or surgery year and reapplying from a resident position is viable. Programs can evaluate your ACGME evaluations as a resident alongside your original application materials. Some applicants have matched on reapplication having completed part or all of a preliminary year.
• Alternative specialty paths: Hematology/oncology, surgical oncology, and interventional radiology address some of the same patient populations using different methods. This is a separate decision that warrants its own analysis—not a default, not a failure, and not a decision to make under match week pressure. If you are at an early stage and genuinely uncertain whether radiation oncology is your only path, explore the alternatives with the same rigor you are applying here.

The applicant who plans for the possibility of a non-match outcome before it happens is better positioned than the applicant who encounters it without preparation. Planning for contingencies does not reduce your probability of matching; it reduces the cost of the tail risk.